Company Data
Catalyst Pharmaceuticals Inc.
Ticker
CPRX
Current Price
$20.59 1.03%
Market Cap
$2.5B
Price Target
Refer to Report
Volume
814.3K
52wk Range
$19 - $26.58
Overview
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.